Background: Compelling evidence indicates that kappa opioid receptor, (KOR) distortions in animals and humans, yet the mechanism of action and clinical relevance of such effects remain unclear. Since abnormalities in preattentional functions and informational processing, are hypothesized to underlie psychotic disorders, the present study has been designed to assess. P the role of KOR on sensorimotor gating. Methods: The effects of the selective KOR agonist U50488 were evaluated on the behavioral paradigm of prepulse inhibition (PPI) of the acoustic startle reflex (ASR), Results: U50488 (1.25, 2.5, and 5 mg/kg, subcutaneous [SC]) induced a dose-dependent reduction which was efficiently prevented by the selective KOR antagonist norbinaltorphimine (nor-BNI. 10 mg/kg, SC), as well as by the atypical antipsychotic clozapine (5, 8 mg/kg, intraperitoneal [IP]) but not by the typical antipsychotic baloperidol (.1.5 mg/kg. IP), Conversely, nor-BNI (10 mg/kg, SC) failed to reverse the PPI disruption mediated by both apomorphine (.25 mg/kg. SC) and dizocilpine (.1 mg/kg, SC). Conclusions. Our results support a pivotal role of KOR in the regulation Pointing to these receptors as a possible neurobiological substrate especially relevant to the clusters of psychosis unresponsive to typical antipsychotics.
Kappa opioid receptor activation disrupts prepulse inhibition of the acoustic startle in rats
FRAU, ROBERTO;FA', MAURO;
2005-01-01
Abstract
Background: Compelling evidence indicates that kappa opioid receptor, (KOR) distortions in animals and humans, yet the mechanism of action and clinical relevance of such effects remain unclear. Since abnormalities in preattentional functions and informational processing, are hypothesized to underlie psychotic disorders, the present study has been designed to assess. P the role of KOR on sensorimotor gating. Methods: The effects of the selective KOR agonist U50488 were evaluated on the behavioral paradigm of prepulse inhibition (PPI) of the acoustic startle reflex (ASR), Results: U50488 (1.25, 2.5, and 5 mg/kg, subcutaneous [SC]) induced a dose-dependent reduction which was efficiently prevented by the selective KOR antagonist norbinaltorphimine (nor-BNI. 10 mg/kg, SC), as well as by the atypical antipsychotic clozapine (5, 8 mg/kg, intraperitoneal [IP]) but not by the typical antipsychotic baloperidol (.1.5 mg/kg. IP), Conversely, nor-BNI (10 mg/kg, SC) failed to reverse the PPI disruption mediated by both apomorphine (.25 mg/kg. SC) and dizocilpine (.1 mg/kg, SC). Conclusions. Our results support a pivotal role of KOR in the regulation Pointing to these receptors as a possible neurobiological substrate especially relevant to the clusters of psychosis unresponsive to typical antipsychotics.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
